Kala Pharmaceuticals's market cap is currently $10.04M. The company's EPS TTM is $-1.71; its P/E ratio is ―; Kala Pharmaceuticals is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $-1.41. See an overview of income statement, balance sheet, and cash flow financials.
